Date Filed | Type | Description |
07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/24/2022 |
4
| Mayer Howard (Director) has filed a Form 4 on Adagio Therapeutics, Inc.
Txns:
| Granted 75,000 options to buy
@ $3.09, valued at
$231.8k
|
|
02/15/2022 |
4
| Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns:
| Disposed/sold 15,000 options to buy
@ $6.44, valued at
$96.6k
Granted 12,500 options to buy
@ $2.44, valued at
$30.5k
|
|
01/19/2022 |
4
| Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns:
| Granted 27,500 shares
@ $0 |
|
08/09/2021 |
4
| Mayer Howard (Director) has filed a Form 4 on Adagio Therapeutics, Inc.
Txns:
| Granted 35,593 options to buy
@ $17, valued at
$605.1k
|
|
08/05/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/02/2021 |
4
| Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns:
| Granted 22,000 shares
@ $0 |
|
10/06/2020 |
4
| Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns:
| Granted 11,000 options to buy
@ $2.98, valued at
$32.8k
|
|
06/19/2020 |
4
| Mayer Howard (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 15,000 options to buy
@ $2.22, valued at
$33.3k
|
|
08/06/2019 |
4
| Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.
Txns:
| Granted 15,000 options to buy
@ $6.44, valued at
$96.6k
|
|
08/06/2019 |
3
| Mayer Howard (Director) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
07/19/2019 |
4
| Mayer Howard (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 5,625 options to buy
@ $3.66, valued at
$20.6k
|
|
06/25/2018 |
4
| Mayer Howard (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 45,000 options to buy
@ $0.99, valued at
$44.6k
|
|
03/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
03/07/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |